Growing community of inventors

Alameda, CA, United States of America

Anthony Purchio

Average Co-Inventor Count = 3.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 24

Anthony PurchioPamela R Contag (4 patents)Anthony PurchioHongbing Zhang (2 patents)Anthony PurchioAmy Holt (2 patents)Anthony PurchioNing Zhang (1 patent)Anthony PurchioKevin P Francis (1 patent)Anthony PurchioKevin A Nawotka (1 patent)Anthony PurchioWeisheng Zhang (1 patent)Anthony PurchioSandy Hashima (1 patent)Anthony PurchioShirley Ma (1 patent)Anthony PurchioZhang Ning (1 patent)Anthony PurchioKevin Nawotka (0 patent)Anthony PurchioAnthony Purchio (6 patents)Pamela R ContagPamela R Contag (25 patents)Hongbing ZhangHongbing Zhang (10 patents)Amy HoltAmy Holt (2 patents)Ning ZhangNing Zhang (6 patents)Kevin P FrancisKevin P Francis (5 patents)Kevin A NawotkaKevin A Nawotka (3 patents)Weisheng ZhangWeisheng Zhang (1 patent)Sandy HashimaSandy Hashima (1 patent)Shirley MaShirley Ma (1 patent)Zhang NingZhang Ning (1 patent)Kevin NawotkaKevin Nawotka (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Xenogen Corporation (6 from 67 patents)


6 patents:

1. 7449567 - Isolation and identification of mouse and human transcription control elements associated with cytochrome expression

2. 7196190 - Methods and compositions for screening for angiogenesis modulating compounds

3. 7115793 - Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression

4. 7056728 - Compositions and methods for use thereof in modifying the genomes of microorganisms

5. 6867348 - Methods and compositions for screening for angiogenesis modulating compounds

6. 6858773 - Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expression

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/11/2026
Loading…